期刊文献+

细胞色素P450 2C19基因多态性对奥美拉唑胶囊抑酸效果的影响 被引量:7

Effects of cytochrome P450 2C19 genetic polymorphism on the acid-inhibitory efficacy of omeprazole capsule
下载PDF
导出
摘要 目的研究细胞色素P4502C19(CYP2C19)基因多态性对奥美拉唑胶囊抑酸效果的影响。方法在15名幽门螺杆菌感染阴性的健康志愿者中,用聚合酶链反应-限制性片段长度多态性方法确定CYP2C19基因型,分为纯合子强代谢型(homEM),杂合子强代谢型(hetEM)和弱代谢型(PM)3组,每组5人。受试者口服奥美拉唑每天20mg,连续8天。分别在服药第1天和第8天,用24h胃内pH测定仪分析24h胃内pH中位值、pH>4及pH>3的总时间。结果24h胃内pH中位值、pH>4和pH>3的总时间,PM组显著高于homEM组和hetEM组(P<0.05)。homEM组和hetEM组的24h胃内pH监测参数,在服药第8天显著高于第1天(P<0.05)。夜间抑酸效果,PM组也优于homEM组和hetEM组(P<0.05)。结论CYP2C19基因多态性对奥美拉唑的抑酸效果及夜间酸突破现象均有明显影响。 Objective To investigate whether the acid - inhibitory efficacy of omeprazole capsule are dependent of the cytochromeP450 2C19 ( CYP 2C19) genotype status. Methods Fifteen H. pylori -negative healthy volunteers were invited and approved to participate in this study , whose CYP2 C19 genotype status were determined by polymerase chain reaction -restriction fragment length polymorphism method. There were five homozygous extensive metabolisers (hom EMs ) , five heterozygous extensive metabolisers( het EMs ) and five poor metabolisers ( PMs ). After orally received omeprazole 20 mg once daily in the morning, the intragastric pH values were monitored for 24 h by Digitrapper pH on the first day and the eighth day. Results Significant differences were observed in median intragastric pH values, pH 〉 4 holding time, pH 〉 3 holding time between PMs and the others (horn EMs and het EMs) after a single dose or repeated doses. The increased intragastric pH values from single to repeated doses were more significant in the hom EM and het EM groups than that in PM groups. The acid suppression at night (22:00 -6:00) in PM groups was also more significant than that in the horn EM and her EM groups. Conclusion CYP 2C19 genetic polymorphism has significant influence on acid - inhibitory efficacy of omeprazole and nocturnal acid breakthrough.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2006年第1期31-34,共4页 The Chinese Journal of Clinical Pharmacology
基金 安徽省教育厅基金资助项目(2003kj199)
关键词 细胞色素P450 2C19 基因多态性 奥美拉唑胶囊 cytochromeP450 2C19 genetic polymorphism omeprazole capsule
  • 相关文献

参考文献9

  • 1de Morais SM,Wilkinson GR,Blaisdell J,et al.Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese[J].Mol Pharmacol,1994; 46:594 -598..
  • 2Furuta T,Ohashi K,Kosuge K,et al.CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans[J].Clin Pharmacol Ther,1999; 65:552-561.
  • 3Shirai N,Furuta T,Moriyama Y,et al.Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH[J].Aliment Pharnacol Ther,2001; 15:1929-1937.
  • 4Shimatani T,Inoue M,Kuroiwa T,et al.Effect of omeprazole 10 mg on intragastric pH in three different CYP2C19 genotypes,compared with omeprazole 20 mg and lafutidine 20 mg,a new H2 -receptor antagonist[J].Aliment Pharmacol Ther,2003;18:1149-1157.
  • 5Yamada S,Onda M,Kato S,et al.Genetic differences in CYP2C19 single nucleotide polymorphisms among four Asian populations[J].J Gastroenterol,2001 ;36:669-672.
  • 6Sohn DR,Kobayashi K,Chiba K,et al.Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4-hydroxylation recruited from an Oriental population[J].J Pharmacol Exp Ther,1992; 262:1195-1202.
  • 7Ieiri I,Kubota T,Urae A,et al.Pharuaeokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles,CYP2C19M1 in exon 5 and CYP2C19M2 in exon 4,in Japanese subjects[J].Clin Pharmacol Ther,1996; 59:647-653.
  • 8Tytgat GN.Shortcomings of the first-generation proton pump inhibitors[J].Eur J Gastroenterol Hepatol,2001; 13(Suppl.1):S29 -33.
  • 9Sakai T,Aoyama N,Kita T,et al.CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects[J].Pharm Res,2001 ;18:721 -727.

同被引文献53

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部